Free Trial

Cellebrite DI (CLBT) SEC Filings & 10K Form

Cellebrite DI logo
$18.35 -0.21 (-1.13%)
Closing price 04:00 PM Eastern
Extended Trading
$18.30 -0.05 (-0.30%)
As of 04:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cellebrite DI SEC Filings

DateFilerForm TypeView
02/28/2025
3:04 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
3:04 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
GEE DAVID NICHOLAS (Reporting)
GEE DAVID NICHOLAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
3:42 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
4:26 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Jewell Marcus (Reporting)
Form 144/A
02/19/2025
3:30 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Shapira Ayala Berler (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
8:12 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Jewell Marcus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
6:15 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2025
8:08 AM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G
02/11/2025
11:52 AM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP SAFERWORLD, LIMITED PARTNERSHIP (Filed by)
Form SCHEDULE 13G/A
02/10/2025
5:19 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
SUNCORPORATION (Filed by)
Form SCHEDULE 13G/A
01/15/2025
3:20 PM
Carmil Yosef (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
7:15 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2024
3:48 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
GEE DAVID NICHOLAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
4:08 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Keinan Elly (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/09/2024
5:12 PM
Baudot-Trajtenberg Nadine (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
12:30 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gruber Dafna (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:24 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Shapira Ayala Berler (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
3:32 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
3:49 PM
Armon Ronnen (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
6:19 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Jewell Marcus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
9:50 AM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
9:32 AM
Carmil Yosef (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
9:39 AM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
4:59 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
GEE DAVID NICHOLAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
8:36 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
GEE DAVID NICHOLAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
7:30 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2024
6:20 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
6:15 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
3:34 PM
Carmil Yosef (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/19/2024
3:01 PM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/17/2024
3:33 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
TWC Tech Holdings II, LLC (Filed by)
Form SC 13D/A
09/16/2024
3:45 PM
Carmil Yosef (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
6:16 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
4:00 PM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2024
5:37 AM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
7:12 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/29/2024
5:07 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
TWC Tech Holdings II, LLC (Filed by)
Form SC 13D/A
08/29/2024
6:06 AM
Carmil Yosef (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2024
5:55 AM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/27/2024
7:01 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/20/2024
3:26 PM
Armon Ronnen (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Jeff Brown's Urgent March 17th Alert (Ad)

Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.

I urge you to watch this video now.
08/15/2024
6:00 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
6:15 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
6:16 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
6:15 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/18/2024
3:11 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
3:22 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
3:29 PM
Carmil Yosef (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2024
3:24 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2024
3:37 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Cole Lisa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2024
6:15 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2024
8:57 AM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP Investments , LP (0002002785) (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2024
7:22 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Cole Lisa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/12/2024
4:03 PM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 20-F/A
03/21/2024
8:10 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/21/2024
6:10 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/15/2024
3:17 PM
Carmil Yosef (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2024
11:38 AM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP SAFERWORLD, LIMITED PARTNERSHIP (Filed by)
Form SC 13G/A
03/06/2024
6:15 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CLBT) was last updated on 3/3/2025 by MarketBeat.com Staff
From Our Partners